Skip to main content
Minesh Nandi, MD, Internal Medicine, Worcester, MA, UMass Memorial Medical Center

MineshNandiMD

Internal Medicine Worcester, MA

Hematology/Oncology

Hematolgy Oncology Fellow @ University of Massachusetts

Dr. Nandi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nandi's full profile

Already have an account?

Summary

  • I am currently fellow in a Hematology/Oncology at the University of Massachusetts.

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2020 - 2023
  • AtlantiCare Regional Medical Center
    AtlantiCare Regional Medical CenterResidency, Internal Medicine, 2017 - 2020
  • American University of Antigua College of Medicine
    American University of Antigua College of MedicineClass of 2017
  • Rutgers University
    Rutgers UniversityCell Biology and Neuroscience

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • MA State Medical License
    MA State Medical License 2020 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Ibuprofen-induced thrombotic thrombocytopenic purpura  
    Benmoussa. J, MD, Chevenon. M, MSc, Nandi.M, BSc, Nfonoyim. J, MD, Forlenza T, MD, The American Journal of Emergency Medicine, Volume 34, Issue 5, 942.e5 - 942.e7.
  • A Fatal Case of Primary Amebic Meningoencephalitis from Recreational Waters” Department of Neurocritical Care Medicine  
    Minesh Nandi M.D, Saif Faeik M.D, Manish Trivedi M.D, Edward Hamaty, Jr D.O, Critical Care Medicne
  • A Rare Case of Intracranial Germinoma in a 21-year-old Romanian Male  
    Minesh Nandi, Case Report in Oncological Medicine, 1/4/2020
  • Join now to see all

Abstracts/Posters

  • Somatostatin Receptor Activation by Agonist-like Antibodies can Reverse miR-200c/ZEB1 Dependent Cell Dedifferentiation and Increase Cell Death in Neuroendocrine Tumor ...
    Nandi M, North American Neuroendocrine Tumor Society
  • Anti-SSTR antibodies can reverse neuroendocrine tumor cellular dedifferentiation induced by neutralizing EMT regulator miR- 200c in pancreatic neuroendocrine tumor BON...
    Leu F, Nandi M, C Wong, Pancreas, 4/15/2010

Committees

  • Chair, Research Committee 2018 - Present
  • Associate Member, Ethics Committee
  • Associate Member, Community Engagement

Research History

  • Research Associate Scientist IIIR&D of novel therapeutic antibody-based treatment for neuroendocrine and pancreatic tumors.Carried out receptor functioning studies using multiple techniques including live cell imaging, pseudo-confocal microscopy, use of nanocrystals to determine the functionality of the monoclonal antibody

Professional Memberships

Other Languages

  • Hindi, Gujarati

Hospital Affiliations